Leinco Technologies, Inc.'s Anti-Human IL 12/23 (Briakinumab) - 50 mg monoclonal antibody. The Anti-Human IL 12/23 (Briakinumab) - 50 mg Antibody was generated using IL12B, and Interleukin 12B as the antigen. It reacts with Homo Sapiens, and Human. This antibody has been shown to work in applications such as: EIA, Immunoassay, Precipitation, Blotting, Block/Neutralize/Inhibit, ELISA, Flow Cytometry, Functional Assay, Immunofluorescence, Immunoprecipitation, and Western Blot.